← USPTO Patent Grants

Composition for preventing, alleviating or treating cancer

Grant US12576077B2 Kind: B2 Mar 17, 2026

Assignee

CKP THERAPEUTICS, INC.

Inventors

Ki Cheong Park, Seokmo Kim

Abstract

A compound represented by Formula 1 according to the present disclosure, when used in combination with an anticancer drug, may significantly improve the anticancer effect of the anticancer drug, and may induce the same anticancer effect even when the anticancer drug is used in a significantly smaller amount than the conventionally used amount, thereby reducing the side effects caused by administration of the anticancer drug. Furthermore, the compound represented by Formula 1 makes it possible to effectively prevent, alleviate or treat either anticancer-resistant cancer or cancer which recurs or metastasizes after anticancer drug treatment.

CPC Classifications

A61K 2300/00 A61K 31/282 A61K 31/337 A61K 31/44 A61K 31/4745 A61K 31/475 A61K 31/506 A61K 31/513 A61K 31/519 A61K 31/5377 A61K 31/5545 A61K 31/555 A61K 31/704 A61K 31/7068 A61K 33/243 A61K 38/179 A61K 38/212 A61K 39/3955 A61P 35/00 C07D 471/04

Filing Date

2023-08-28

Application No.

18238961

Claims

13